Q & M Dental Group (Singapore) Limited (SGX:QC7)
Singapore · Delayed Price · Currency is SGD 0.5400
0.00 (0.00%)
Aug 28, 2026, 5:04 PM SGT
SGX:QC7 Income Statement
Financials in millions SGD. Fiscal year is January - December.
Millions SGD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 208.31 | 197.23 | 180.67 | 182.72 | 181.21 | 205.6 | |
Revenue Growth | 15.56% | 9.16% | -1.12% | 0.83% | -11.86% | 49.40% |
Cost of Revenue | 153.91 | 142.16 | 128.35 | 132.21 | 134.91 | 135.97 |
Gross Profit | 54.4 | 55.06 | 52.32 | 50.52 | 46.3 | 69.63 |
Selling, General & Admin | 0.34 | 0.34 | - | 0.23 | 0.27 | 0.35 |
Other Operating Expenses | 13.98 | 12.39 | 10.58 | 10.59 | 9.94 | 10.24 |
Operating Expenses | 35.62 | 32.44 | 28.55 | 28.59 | 27.27 | 24.16 |
Operating Income | 18.78 | 22.63 | 23.77 | 21.92 | 19.03 | 45.47 |
Interest Expense | -7.77 | -6.44 | -5.37 | -5.66 | -3.91 | -3.02 |
Interest & Investment Income | 0.95 | 0.56 | - | 0.06 | 0.03 | 0.01 |
Earnings From Equity Investments | - | -0.1 | 0.13 | -0.08 | -0.54 | -0.47 |
Currency Exchange Gain (Loss) | 0.27 | 0.2 | 0.06 | -0.09 | -0.01 | -0.04 |
Other Non Operating Income (Expenses) | - | - | 1.04 | - | -0.09 | -0.08 |
EBT Excluding Unusual Items | 12.23 | 16.84 | 19.63 | 16.16 | 14.51 | 41.88 |
Impairment of Goodwill | - | - | -2.54 | -2.39 | - | - |
Gain (Loss) on Sale of Investments | -15.48 | -19.82 | - | - | - | 4.37 |
Gain (Loss) on Sale of Assets | 1.51 | 0.34 | 0.41 | 0.08 | 0.03 | 0.01 |
Asset Writedown | -1.19 | -0.84 | -3.12 | -0.18 | -0.26 | -0.2 |
Other Unusual Items | 15.66 | 15.66 | - | - | - | 0.6 |
Pretax Income | 12.74 | 12.19 | 14.38 | 13.66 | 14.28 | 46.65 |
Income Tax Expense | 1.76 | 2.27 | 1.69 | 2.59 | 2.42 | 7.3 |
Earnings From Continuing Operations | 10.98 | 9.92 | 12.69 | 11.07 | 11.86 | 39.36 |
Minority Interest in Earnings | -0.63 | -0.61 | 1.57 | 0.44 | -0.55 | -8.89 |
Net Income | 10.35 | 9.31 | 14.26 | 11.52 | 11.31 | 30.47 |
Net Income to Common | 10.35 | 9.31 | 14.26 | 11.52 | 11.31 | 30.47 |
Net Income Growth | 22.25% | -34.72% | 23.85% | 1.84% | -62.89% | 54.67% |
Shares Outstanding (Basic) | 945 | 947 | 947 | 946 | 941 | 944 |
Shares Outstanding (Diluted) | 945 | 947 | 947 | 946 | 941 | 944 |
Shares Change | -0.38% | -0.07% | 0.10% | 0.60% | -0.31% | -0.07% |
EPS (Basic) | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 | 0.03 |
EPS (Diluted) | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 | 0.03 |
EPS Growth | 22.53% | -34.67% | 23.73% | 1.40% | -62.83% | 54.77% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 28.5 | 31.93 | 32.15 | 27.52 | 24.24 | 43 |
Free Cash Flow Per Share | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.05 |
Dividend Per Share | 0.008 | 0.008 | 0.011 | 0.007 | 0.010 | 0.036 |
Dividend Growth | -25.45% | -25.45% | 59.42% | -31.00% | -72.22% | 380.00% |
Gross Margin | 26.11% | 27.92% | 28.96% | 27.65% | 25.55% | 33.87% |
Operating Margin | 9.01% | 11.47% | 13.16% | 12.00% | 10.50% | 22.11% |
Profit Margin | 4.97% | 4.72% | 7.90% | 6.30% | 6.24% | 14.82% |
Free Cash Flow Margin | 13.68% | 16.19% | 17.79% | 15.06% | 13.38% | 20.91% |
EBITDA | 24.66 | 28.1 | 28.74 | 26.67 | 23.68 | 49.59 |
EBITDA Margin | 11.84% | 14.25% | 15.90% | 14.60% | 13.07% | 24.12% |
D&A For EBITDA | 5.89 | 5.48 | 4.96 | 4.75 | 4.66 | 4.13 |
EBIT | 18.78 | 22.63 | 23.77 | 21.92 | 19.03 | 45.47 |
EBIT Margin | 9.01% | 11.47% | 13.16% | 12.00% | 10.50% | 22.11% |
Effective Tax Rate | 13.78% | 18.60% | 11.72% | 18.96% | 16.96% | 15.64% |